Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure

被引：5
作者：
Sonmez, M. [1 ]
Cobanoglu, U. [2 ]
Ovali, E. [1 ]
Omay, S. B. [1 ]
机构：
[1] Karadeniz Tech Univ, Sch Med, Dept Haematol, Trabzon, Turkey
[2] Karadeniz Tech Univ, Sch Med, Dept Pathol, Trabzon, Turkey
来源：
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2008年 / 33卷 / 03期
关键词：
D O I：
10.1111/j.1365-2710.2008.00916.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 8 条
[1]  
*BRITST MYERS SQUI, 2006, SPRYC PRESCR INF PER
[2]   Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis [J].
Cortes, Jorge ;
Rousselot, Philippe ;
Kim, Dong-Wook ;
Ritchie, Ellen ;
Hamerschlak, Nelson ;
Coutre, Steven ;
Hochhaus, Andreas ;
Guilhot, Francois ;
Saglio, Giuseppe ;
Apperley, Jane ;
Ottmann, Oliver ;
Shah, Neil ;
Erben, Philipp ;
Branford, Susan ;
Agarwal, Prasheen ;
Gollerkeri, Ashwin ;
Baccarani, Michele .
BLOOD, 2007, 109 (08) :3207-3213
[3]   Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase [J].
Guilhot, Francois ;
Apperley, Jane ;
Kim, Dong-Wook ;
Bullorsky, Eduardo O. ;
Baccarani, Michele ;
Roboz, Gail J. ;
Amadori, Sergio ;
de Souza, Carmino A. ;
Lipton, Jeffrey H. ;
Hochhaus, Andreas ;
Heim, Dominik ;
Larson, Richard A. ;
Branford, Susan ;
Muller, Martin C. ;
Agarwal, Prasheen ;
Gollerkeri, Ashwin ;
Talpaz, Moshe .
BLOOD, 2007, 109 (10) :4143-4150
[4]   Current and emerging treatment options in chronic myeloid leukemia [J].
Jabbour, Elias ;
Cortes, Jorge E. ;
Giles, Francis J. ;
O'Brien, Susan ;
Kantarjian, Hagop M. .
CANCER, 2007, 109 (11) :2171-2181
[5]   The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias [J].
Maekawa, Taira ;
Ashihara, Eishi ;
Kimura, Shinya .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (05) :327-340
[6]   Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study [J].
Ottmann, Oliver ;
Dombret, Herve ;
Martinelli, Giovanni ;
Simonsson, Bengt ;
Guilhot, Francois ;
Larson, Richard A. ;
Rege-Cambrin, Giovanna ;
Radich, Jerald ;
Hochhaus, Andreas ;
Apanovitch, Anne Marie ;
Gollerkeri, Ashwin ;
Coutre, Steven .
BLOOD, 2007, 110 (07) :2309-2315
[7]   Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias [J].
Talpaz, Moshe ;
Shah, Neil P. ;
Kantarjian, Hagop ;
Donato, Nicholas ;
Nicoll, John ;
Paquette, Ron ;
Cortes, Jorge ;
O'Brien, Susan ;
Nicaise, Claude ;
Bleickardt, Eric ;
Blackwood-Chirchir, M. Anne ;
Iyer, Vishwanath ;
Chen, Tai-Tsang ;
Huang, Fei ;
Decillis, Arthur P. ;
Sawyers, Charles L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24) :2531-2541
[8]   The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants [J].
Tokarski, John S. ;
Newitt, John A. ;
Chang, Chieh Ying J. ;
Cheng, Janet D. ;
Wittekind, Michael ;
Kiefer, Susan E. ;
Kish, Kevin ;
Lee, Francis Y. F. ;
Borzillerri, Robert ;
Lombardo, Louis J. ;
Xie, Dianlin ;
Zhang, Yaqun ;
Klei, Herbert E. .
CANCER RESEARCH, 2006, 66 (11) :5790-5797
1